InterVenn Biosciences, a precision diagnostics company advancing liquid biopsy with glycoproteomics, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology ...

Increased patient testing and less lab staff to perform manual tasks have created a bottleneck for care Now, automation found in high-volume labs is accessible no matter a lab’s footprint or volume ...

Aranscia will provide software solutions to facilitate the delivery of results from InterVenn's flagship glycoproteomic liquid biopsy test.

After a patient with a high risk of sepsis spikes a fever or develops other symptoms, a delay in hours, let alone days, to place the patient on the right drug can dramatically increase mortality rates ...

QIAGEN N.V. QGEN recently announced the launch of EZ2 Connect MDx for use in diagnostic laboratories. This makes the in-vitro devices (IVD) platform for automated sample processing available for ...

Reagent Strip for Urinalysis , Routine Urinalysis, check-up analysis in laboratory. The implementation of a standardized workflow for the diagnosis and management of urinary tract infections improved ...

Clinicians and other workers in the healthcare delivery chain are always looking for ways to improve workflow. Similarly, hospital and health system leadership always desire new ways to develop their ...

Psychiatric Medical Care prides itself on delivering evidence-based care services. It wanted the ability to drive patient treatment through their responses to evidence-based testing. The healthcare ...

Epredia has offered the technology behind the E1000 Dx since 2017 for research use only in the U.S. and as an IVD instrument in Europe. In the E1000 Dx, Epredia has refined the technology and software ...

Hospitals and health systems face growing pressure to outsource their clinical laboratories amid an increasing number of healthcare mergers and acquisitions. As healthcare leaders weigh the perceived ...

A clinical workflow designed to improve referrals to exercise for patients undergoing cancer treatment was feasible for staff and accepted by patients. Researchers developed and assessed a clinical ...